BioAmber

BioAmber

A chemical company that uses biotechnology and chemical catalysis to transform renewable feedstock into chemicals.

BioAmber is a chemical company that uses biotechnology and chemical catalysis to transform renewable feedstock into chemicals that is headquartered in Montreal, Quebec and was founded in 2008. The company uses industrial biotechnology and chemical catalysis to create chemicals for several consumer products such as plastics, personal care products, resins, and food additives from renewable feedstocks.

Acquisitions

LYC Biotechnology

On October 26, 2018 BioAmber's non-operational plant in Sarnia, Ontario was sold to LYC Biotechnology for $4.34 million as a US and Canada court supervised liquidation of BioAmber. The deal required court supervision at the request of BioAmber. BioAmber made the following public statement that the company was 'facing a liquidity crisis' and it had an 'inability to raise capital on public markets as a result of its recent delisting from the New York Stock Exchange and the Toronto Stock Exchange. On June 18, 2019 LYC Biotechnology released a statement telling the public they plan on making the plant in Sarnia, Ontario operational by fall 2019.

Timeline

February 22, 2012

BioAmber raises a $30,000,000 series C round from Sofinnova Partners, NAXOS Capital Partners, Cliffton Group, Mitsui & Co. and Lanxess.

May 4, 2011

BioAmber raises a $45,000,000 series B round from NAXOS Capital Partners.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
2 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Curtis Gunn

Investor

Louise Batchelor

Employee

Patrick Piot

Employee

Paul Petersen

Employee

Sara Weinheimer

Investor

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.